UFP Technologies, Inc. (NASDAQ:UFPT – Get Free Report) Director Daniel C. Croteau sold 6,846 shares of the business’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $228.41, for a total transaction of $1,563,694.86. Following the sale, the director now directly owns 1,785 shares of the company’s stock, valued at approximately $407,711.85. This trade represents a 79.32 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
UFP Technologies Stock Up 1.2 %
Shares of NASDAQ:UFPT opened at $215.37 on Thursday. UFP Technologies, Inc. has a 52 week low of $188.50 and a 52 week high of $366.41. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.43 and a current ratio of 2.57. The company has a market capitalization of $1.65 billion, a PE ratio of 30.72 and a beta of 1.04. The company has a 50 day moving average price of $254.82 and a two-hundred day moving average price of $287.66.
UFP Technologies (NASDAQ:UFPT – Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.45. The company had revenue of $144.07 million during the quarter, compared to analysts’ expectations of $141.67 million. UFP Technologies had a net margin of 11.74% and a return on equity of 18.92%.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of UFP Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, January 23rd.
View Our Latest Analysis on UFP Technologies
About UFP Technologies
UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.
Read More
- Five stocks we like better than UFP Technologies
- 10 Best Airline Stocks to Buy
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- High Dividend REITs: Are They an Ideal Way to Diversify?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.